Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hawkins

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Clinical & Experimental Metastasis|November 12, 2005
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasisBorhane Annabi, Mounia Bouzeghrane, Jean-Christophe Currie, et al.
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
The Oncologist|March 15, 2019
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)Manuela Schmidinger, Aristotelis Bamias, Giuseppe Procopio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II studyPeter Mulders, Robert Hawkins, Paul Nathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trialAlain Ravaud, Robert Hawkins, Jason P Gardner, et al.
Journal of Viral Hepatitis|November 22, 2024
Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination EffortKuo Chao Yew, Alyssa Shin Yee Sim, Robert Hawkins, et al.
Human Gene Therapy|March 28, 2026
In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>Reno Debets, Robert Hawkins, David Gilham, et al.
Cancer Medicine|July 22, 2014
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countriesCamillo Porta, Antonin Levy, Robert Hawkins, et al.
Human Gene Therapy|June 18, 2026
In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>Reno Debets, Robert Hawkins, David Gilham, et al.
Clinical Genitourinary Cancer|June 15, 2019
Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell CarcinomaGiuseppe Procopio, Aristotelis Bamias, Manuela Schmidinger, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Clinical & Experimental Metastasis|November 12, 2005
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasisBorhane Annabi, Mounia Bouzeghrane, Jean-Christophe Currie, et al.
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
The Oncologist|March 15, 2019
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)Manuela Schmidinger, Aristotelis Bamias, Giuseppe Procopio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II studyPeter Mulders, Robert Hawkins, Paul Nathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trialAlain Ravaud, Robert Hawkins, Jason P Gardner, et al.
Journal of Viral Hepatitis|November 22, 2024
Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination EffortKuo Chao Yew, Alyssa Shin Yee Sim, Robert Hawkins, et al.
Human Gene Therapy|March 28, 2026
In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>Reno Debets, Robert Hawkins, David Gilham, et al.
Cancer Medicine|July 22, 2014
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countriesCamillo Porta, Antonin Levy, Robert Hawkins, et al.
Human Gene Therapy|June 18, 2026
In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>Reno Debets, Robert Hawkins, David Gilham, et al.
Clinical Genitourinary Cancer|June 15, 2019
Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell CarcinomaGiuseppe Procopio, Aristotelis Bamias, Manuela Schmidinger, et al.
Pageof 11